Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

NCT02082197 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02082197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02082197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Withdrawn
Start date
March 31, 2014
Completion date
June 30, 2015
Enrollment
0 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, testosterone deficiency